Key points are not available for this paper at this time.
Posaconazole was similar to fluconazole for prophylaxis against fungal infections among patients with GVHD. It was superior in preventing invasive aspergillosis and reducing the rate of deaths related to fungal infections. (ClinicalTrials.gov number, NCT00034645 ClinicalTrials.gov.).
Ullmann et al. (Thu,) studied this question.